Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Seminars in Oncology|August 31, 2015
Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future ChallengesJoseph Obeid, Yinin Hu, Craig L Slingluff
Scientific Reports|October 28, 2020
Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissuesMinyoung Kwak, Gulsun Erdag, Craig L Slingluff
Annals of Surgery|March 17, 2015
Localization of the Sentinel Lymph Node in Melanoma Without Blue DyeYinin Hu, Patrick D Melmer, Craig L Slingluff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Peptide and dendritic cell vaccinesCraig L Slingluff, Victor H Engelhard, Soldano Ferrone
Journal of Cutaneous Pathology|July 26, 2002
Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasizeLiana Abramova, Craig L Slingluff, James W Patterson
Annals of Surgical Oncology|December 20, 2024
The Landmark Series: Cancer Vaccines for Solid TumorsEmily K Ninmer, Feifan Xu, Craig L Slingluff
Journal of Surgical Oncology|December 13, 2021
Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelinesJeremy Sharib, Craig L Slingluff, Georgia M Beasley
Contemporary Clinical Trials|February 2, 2015
A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanomaNolan A Wages, Craig L Slingluff, Gina R Petroni
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Interface of signal transduction inhibition and immunotherapy in melanomaAmber L Shada, Kerrington R Molhoek, Craig L Slingluff
JAMA Surgery|January 10, 2024
Sentinel Lymph Node Biopsy Calculators for Informed Decision-MakingLynn T Dengel, Russell G Witt, Craig L Slingluff
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Seminars in Oncology|August 31, 2015
Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future ChallengesJoseph Obeid, Yinin Hu, Craig L Slingluff
Scientific Reports|October 28, 2020
Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissuesMinyoung Kwak, Gulsun Erdag, Craig L Slingluff
Annals of Surgery|March 17, 2015
Localization of the Sentinel Lymph Node in Melanoma Without Blue DyeYinin Hu, Patrick D Melmer, Craig L Slingluff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Peptide and dendritic cell vaccinesCraig L Slingluff, Victor H Engelhard, Soldano Ferrone
Journal of Cutaneous Pathology|July 26, 2002
Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasizeLiana Abramova, Craig L Slingluff, James W Patterson
Annals of Surgical Oncology|December 20, 2024
The Landmark Series: Cancer Vaccines for Solid TumorsEmily K Ninmer, Feifan Xu, Craig L Slingluff
Journal of Surgical Oncology|December 13, 2021
Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelinesJeremy Sharib, Craig L Slingluff, Georgia M Beasley
Contemporary Clinical Trials|February 2, 2015
A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanomaNolan A Wages, Craig L Slingluff, Gina R Petroni
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Interface of signal transduction inhibition and immunotherapy in melanomaAmber L Shada, Kerrington R Molhoek, Craig L Slingluff
JAMA Surgery|January 10, 2024
Sentinel Lymph Node Biopsy Calculators for Informed Decision-MakingLynn T Dengel, Russell G Witt, Craig L Slingluff
Pageof 23